From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 294,186 shares, representing 0.87% for KRW 2,998.6 million under the buyback announced on September 20, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,210 KRW | -2.82% | -4.75% | -29.27% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.27% | 16Cr | |
+10.09% | 11TCr | |
+12.72% | 11TCr | |
-5.57% | 2.22TCr | |
-0.67% | 2.13TCr | |
-4.64% | 1.88TCr | |
-6.32% | 1.75TCr | |
-39.36% | 1.72TCr | |
+6.46% | 1.41TCr | |
+34.80% | 1.22TCr |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.